Overview
Middle East Respiratory Syndrome coronavirus (MERS-CoV) is a zoonotic betacoronavirus, first identified in 2012, that causes Middle East Respiratory Syndrome, a severe respiratory illness with a high case-fatality rate. MERS-CoV belongs to the same broad family of coronaviruses as SARS-CoV and SARS-CoV-2, but is a distinct virus with its own epidemiology. Dromedary camels are recognized as a reservoir and source of zoonotic transmission to humans, and limited human-to-human spread has occurred, particularly in healthcare settings. Clinical presentation ranges from mild or asymptomatic infection to severe pneumonia, acute respiratory distress, and multi-organ involvement, with older adults and those with comorbidities at greatest risk. Since its emergence on the Arabian Peninsula, sporadic cases and clusters have continued to be reported, and MERS remains a recognized public-health threat for which there is no specific approved antiviral therapy or widely deployed vaccine. As a member of the coronavirus family, MERS-CoV is studied alongside related emerging coronaviruses with respect to their origins, molecular evolution, diagnosis, clinical management, and pandemic potential. Research published in this broader coronavirus area covers themes such as the molecular evolution and spike-protein characteristics of human and animal coronaviruses, diagnostic RT-PCR assays, cytokine responses, candidate therapeutics, and the interplay between emerging infectious diseases, animals, and public-health responses.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Reducing COVID-19 Risk through Dietary Supplementation of Plant Mannose Binding Lectins
Features of the Emergence and Re-Emergence of Infectious Diseases, Geopolitics and Gain-of-Function Research
The Novel Coronavirus 2019 (COVID-19): A Narrative Review
Animals in the COVID-19 Era: Between Being a source, Victims, or Maybe our Hope to Overcome it!
A General Approach to Modeling Covid-19
Using Human Development Indices to Identify Indicators to Monitor the Corona Virus Pandemic
Effect of Hydroxychloroquine on Clinical Improvement and Mortality Among Patients with COVID-19 Admitted to Four General Hospitals in Saudi Arabia
Molecular Evolutionary Characteristics of the 2019 Novel Coronavirus (SARS-CoV-2) Contracted by Tunisian Citizens : Comparison and Relationship to Other Human and Animal Coronaviruses Based on Spike Glycoprotein-Coding Gene Sequences Analysis
Comparative Analysis of Five Commercial RT-PCR Diagnostic Assay for Detection of Covid-19
Mental Health in The Context of The COVID 19 Pandemic
Cytokine Profiling in COVID-19 Patients in a Tertiary Hospital in Saudi Arabia; the Pre-Storm Phase
How this research is being cited
The 12 articles above have been cited 32 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2025 · Jundishapur Journal of Microbiology
-
2025 · Jundishapur Journal of Microbiology
-
2025 · Inflammopharmacology
-
2025 · Inflammopharmacology
-
2025 · Journal of Clinical Practice and Medical Research
-
2025 · Journal of Clinical Practice and Medical Research
-
2023 · Revista Brasileira de Farmacognosia
-
2023 · Revista Brasileira de Farmacognosia
A sample of recent works citing this journal's research on Middle East Respiratory Syndrome Coronavirus, linking to each citing work.